Abstract

Aims Age is one of the most powerful determinants of prognosis in myocardial infarction, but there is comparatively little recent data across the whole spectrum of acute coronary syndromes (ACS). We examined the impact of increasing age on clinical presentation and hospital outcome in a large sample of patients with ACS.

Methods and results Patients (n=10 253) from the Euroheart ACS survey in 103 hospitals in 25 countries were investigated. There was a significant inverse association between the age and the likelihood of presenting with ST-elevation. For each decade of life, the odds of presenting with ST-elevation decreased by 0.82 [95% confidence interval (CI) 0.79–0.84]; P<0.0001. Elderly patients were considerably less often treated by cardiologists, less extensively investigated, and, when presenting with ST-elevation ACS, less likely to be treated with reperfusion. Compared with patients <55 years, the odds ratios of hospital mortality were 1.87 (1.21–2.88) at age 55–64, 3.70 (2.51–5.44) at age 65–74, 6.23 (4.25–9.14) at age 75–84, and 14.5 (9.47–22.1) among patients ≥85 years, with no major differences across different types of admission or discharge diagnoses.

Conclusion Elderly ACS patients were less likely to present with ST-elevation but had substantial in-hospital mortality, yet they were markedly less intensively treated and investigated.

Acute myocardial infarction, Unstable angina, Coronary disease, Aging

Introduction

In recent years, there has been a shift in the clinical presentation of acute coronary syndromes (ACS) to milder forms, with evidence to suggest that case severity in acute myocardial infarction (AMI) may be decreasing1–3 and that hospitalized patients with AMI have smaller infarcts4 with lower case fatality.5 Concomitantly, there is an increase in the rates of unstable angina,6 which is a milder form of the ACS. Old age is a powerful predictor of mortality of patients with AMI.7–15 Even though the impact of age on clinical presentation and outcome in AMI is well characterized, the effects of age with these emerging characteristics of ACS have not been well studied. With increasing life expectancy, the mean age of ACS patients is growing steadily, emphasizing the need to define the impact of age across the whole spectrum of ACS. Toward this end, we investigated the impact of increasing age on clinical presentation and hospital outcome in a large population of patients with different manifestations of ACS.

Methods

The details of the Euroheart ACS survey have been previously described in detail.16 The survey was performed in clusters composed of academic and non-academic hospitals and hospitals with and without cardiac catheterization laboratories, and cardiac surgery facilities. During the enrolment period lasting from 4 September 2000 to 15 May 2001, 14 271 patients in 25 countries admitted with suspected ACS were registered, of whom 10 484 were finally diagnosed with either AMI or unstable angina. In 231 patients, there were missing data on either age or sex, leaving 10 253 who form the study population for the present analysis.

For all patients, the tentative initial diagnosis made by the attending physicians was recorded on the basis of the initial electrocardiographic pattern: ACS with ST-elevation, ACS without ST-elevation, and ACS with an undetermined electrocardiographic pattern. The full case report form was filled out for patients with a confirmed diagnosis of unstable angina or AMI and categorized according to the discharge diagnosis as either unstable angina, non-Q-wave AMI, or Q-wave AMI. The case report form included details regarding the demographic, clinical, and electrocardiographic characteristics of the patient, the diagnostic and treatment modalities, the in-hospital complications, and the discharge status. Body mass index was calculated as weight in kilograms divided by height in meters squared. Hypertension was defined as previously diagnosed by a physician, receiving medication to lower blood pressure, or known blood pressure values of ≥140 mmHg systolic or ≥90 mm diastolic on two or more occasions. Diabetes was defined as previously diagnosed by a physician. Current smoking was defined as smoking cigarettes up to 1 month before admission. Angina pectoris of recent or prior onset was recorded and defined as chronic if present at least 30 days before admission, or of unknown duration. Hospital mortality was defined as any death occurring before discharge from any cause.

Coronary angiography was done in 5437 patients (53%). Among patients ≥85 years, only 63 patients (13%) underwent coronary angiography, and because they were so few and, in all probability, heavily selected, we excluded them from the analyses pertaining to angiographic findings. The presence of ≥50% stenosis in any of the three main vessels or left coronary main stem was recorded.

Statistical methods

All analyses were performed using the SAS software version 8e. Baseline characteristics of the patients in the study were summarized in terms of frequencies and percentages. Correlations were tested by linear regression, with age as a continuous variable. With respect to angiographic findings, a summary score was created for the number of vessels with significant (>50%) stenosis, ranging from 0 to 3 and tested against age as a continuous variable. To determine whether the age differences in clinical presentation or outcome were due to differences in baseline clinical and demographic characteristics, multiple logistic regression models were fitted with hospital mortality as the dependent variables while controlling for potentially confounding factors. Of the factors present on admission, we considered gender, prior AMI, hypertension, diabetes, chronic angina, prior revascularization, and known prior heart failure. A similar analysis was conducted with ST-elevation ACS as the dependent variable, which also included an interaction term for sex and age. The clustering of observations within countries was taken into account by using multilevel techniques (university/non-university hospital and country). This method adjusts the estimation of model coefficients for the correlation among the observations, which is due to clustering within countries. Because of the large number of statistical comparisons in this report, P<0.01 was considered to provide borderline evidence for an association and P<0.001 was considered significant.

Results

Of the 10 253 patients enrolled in the Euroheart ACS survey, 2321 (23%) were <55 years and 2544 (25%) were ≥75 years. The proportion of women increased from 17% among patients aged <55 to 56% among patients aged ≥85 (Table 1). The distribution of coronary risk factors varied strongly with age, with few exceptions. Younger patients were more often obese and smokers, and they had a higher prevalence of a positive family history, whereas older patients had more hypertension and diabetes. Prior angina, prior AMI, cerebrovascular events, and heart failure prior to admission were more prevalent with increasing age, as were use of aspirin, beta-blockers, and diuretics.

In the youngest age group, <55 years, 56% of men and 44% of women presented with ST-elevation ACS (Table 2). This proportion decreased with age for the men, whereas there was no significant decrease with age among women. The proportion of ACS with undetermined ECG pattern increased with age. With respect to diagnosis at discharge, the proportion of ACS patients <55 years with Q-wave MI was 44% for men and 29% for women, decreasing to 33% for men 85 years and older, whereas there was no decrease with age in women. The majority of patients in all age groups presented with typical anginal pain, but less frequently so with increasing age. Conversely, the proportion presenting with heart failure (Killip class 3–4) increased markedly with age.

The proportion of patients undergoing a coronary angiogram decreased with age (Table 3). The proportion with a normal coronary angiogram was low overall and became less common with age. Almost one in five had a left main stenosis among patients aged 75–84, and approximately half had either left main stenosis ≥50% or three-vessel disease.

Complications such as heart failure or pulmonary oedema or shock were increasingly more common with age, particularly pulmonary oedema, which occurred in 18% of men and 16% of women 85 years or older (Table 4). Overall, over 40% of ACS patients ≥85 years displayed some form of heart failure, including shock, during their hospital stay. Atrial fibrillation occurred in few of the youngest patients, but in 16% of men and 9% of women ≥85 years. Recurrent ischaemia and re-infarction increased only very slightly with age in men and not at all in women.

Of patients who were <55 years, 91% of men and 85% of women were treated in a coronary care unit or cardiology ward from the start (Table 5). One in five of patients aged 75–84, and one in four among those aged ≥85, were initially treated in non-cardiology units. Among patients presenting with ST-elevation and presenting within 12 h, only 31 and 21% among men and women, respectively, ≥85 years were treated with primary reperfusion, compared with 70% of men and 76% of women <55 years. Use of angiography and evaluation of left ventricular function decreased markedly with age. Angiotensin converting enzyme inhibitors prescribed on discharge were slightly higher in the higher age groups, whereas prescription of beta-blockers and statins were lower.

The proportion of ST-elevation ACS decreased with age, also after considering potential confounders (Table 6). For each decade of life, the odds of presenting with ST-elevation decreased by 0.82 (95% CI 0.79–0.84); P<0.0001 (data not shown). Overall, in-hospital death increased from 1% among patients <55 years to 17% in patients ≥85 years. There were no significant interactions between age and type of ACS, or type of AMI, and hospital mortality (all P>0.2). The overall worst prognosis was found among patients with an undetermined electrocardiogram at admission, but this was largely due to the high average age in this category. Introducing potential confounders into the models including random effects in a multilevel analysis (university/non-university hospital and country) did not influence the odds ratios associated with age to any great extent. Slightly more than half of the patients were ≥65 years, but 81% of the deaths occurred in this group.

Discussion

Major findings

Despite improvement in treatment in ACS, the short-term outcome in elderly patients is still very poor. In this international cohort of comparatively unselected ACS patients, we found that overall in-hospital mortality was <5%, but this varied widely across the different ACS and across age groups. For example, in-hospital mortality was <1% in patients aged <55 without ST-elevation, whereas almost one in four of patients ≥85 years with ST-elevation ACS died. Older patients had less ST-elevation ACS and Q-wave AMI but had more ACS with undetermined ECG pattern, which, in turn, had a poor prognosis, as described in a prior publication.17 The risk factor pattern also varied with age, in that younger patients more often had a positive family history, were smokers, or obese, whereas older patients more often had a history of diabetes, hypertension or prior cardiovascular disease, and more medical treatment. Heart failure and atrial fibrillation were common complications during the hospital stay and were significantly more common with higher age, whereas recurrent ischaemia and re-infarction displayed only weak or non-existent associations with age.

Risk factors and treatments

Manifestations of coronary disease in populations undergo rapid changes over time. In many European countries, as well as in the USA, there have been decreases in the incidence of AMIs18,19 and in mortality from coronary disease.20 Although these changes have not been universal, most of the participating centres in the Euroheart ACS survey represent countries with these characteristics. Another feature of recent developments is that the severity of ACS seems to be decreasing,1–3 with better prognosis.4,5 To a large extent, this will be due to better treatment.19 Out-of-hospital mortality, however, has also decreased,21 indicating that other factors, such as changes in risk factor pattern may play a role.22 One recent study found that modest reductions in major risk factors led to gains in life-years four times higher than did the various treatments.23 The different risk factor patterns in younger and older patients might reflect variations related to aging and differences between birth cohorts. To what extent elderly patients would benefit from better implementation of proven therapies or improvement of risk factors remains undetermined.

Prior studies

Relative odds of 1.44 and 1.82 for hospital mortality for a 10 year increment in age in women and men, respectively, have been found in AMI patients.24 Other studies, however, in non-ST-elevation ACS have found higher increments in short-term mortality with age.25 Among Spanish patients with AMI, and investigated from 1995 to 2001, hospital mortality almost doubled from each age group from 2.6% in patients <55 years to 25.8% in the >84 years group, figures similar to that of the present study,26 even though, unlike the Euroheart survey, only patients treated in coronary care units or intensive care were included. Improvement in hospital outcome seems to have been greater in younger age groups. In the Worcester study, improvement in outcome over two decades was demonstrated to be less in older patients.8

Some of the improvement in younger patients could be due to the fact that proven therapies are better implemented among the younger patients. A substantial proportion of patients who are eligible for reperfusion therapy still do not receive this treatment, particularly among the elderly27,28 although a benefit has been demonstrated also in the elderly,29 and other proven therapies are also underused,13 even in the absence of contraindications.30 Despite having more severe and extensive coronary disease, elderly patients have been shown to receive less aggressive anti-ischaemic therapy and to be less likely to undergo coronary angiography, with fewer revascularization procedures than their younger counterparts.31 Consistent with previous studies,32 older patients had less typical symptoms which partly might explain their different treatment. However, although older patients have an increased risk for major bleeding, a routine early invasive strategy has been shown to significantly improve ischaemic outcomes in elderly patients with non-ST-segment elevation ACS.33 This study supports the notion that older patients may not be as well treated as they should be, and consequently, there may be considerable scope for improvement with respect to hospital outcome in elderly patients.

Limitations

In the Euroheart ACS survey, there was no strict validation of the AMI or unstable angina diagnoses. The discharge diagnosis of the attending physician was accepted. About a quarter of patients diagnosed with AMI had normal creatine kinase status, indicating either that the test was not done within the optimal time frame or that the traditional definition was used, with symptoms and electrocardiographic changes sufficient to diagnose infarction.34 Likewise, 23% of patients diagnosed with unstable angina had elevated creatine kinase, although for the most part only moderately so. The new definition of AMI was published on the same day as this survey started,34 and these inconsistencies reflect clinical practice during this transitional period. Even so, the differences in mortality between different diagnoses were considerable. The age gradient with respect to mortality, however, was similar across all ACS diagnoses.

Conclusions

In this large survey of ACS patients from 25 countries in Europe and the Mediterranean basin, we found that old age remains a strong predictor of increased hospital mortality across all types of ACS. Old patients with ACS have their hospital course frequently complicated, in particular, with heart failure. Young patients had comparatively low mortality, four out of five deaths were in patients ≥65years, indicating that improvement in hospital care for older patients may potentially save a substantial number of lives. However, more detailed data with respect to comorbid conditions and contraindications are needed to estimate the size of this potential benefit.

Acknowledgement

The Euroheart ACS survey was sponsored by Schering-Plough and Centocor. The Swedish participation was supported by the Swedish Heart and Lung Foundation. We thank Georg Lappas for help with the statistical analyses.

Conflict of interest: none declared.

Table 1

Baseline risk factors and prior disease by age in the Euroheart ACS

Age group  <55 55–64 65–74 75–84 85+ P for trend 
Men  1915 1794 1946 1058 211  
Women   406  604 1046 1002 271  
% Women  17.5 (406) 25.2 (604) 35.0 (1046) 48.6 (1002) 56.2 (271) <0.0001 
Obese (>30 kg m−2)a Men 23.4 (410) 21.9 (358) 17.7 (303) 12.8 (111) 6.4 (9) <0.0001 
 Women 27.1 (100) 33.6 (181) 28.1 (251) 21.8 (171) 12.2 (21) <0.0001 
Diabetes mellitus Men 13.5 (259) 23.9 (429) 25.2 (491) 22.9 (242) 24.2 (51) <0.0001 
 Women 20.4 (83) 27.3 (165) 30.5 (319) 32.6 (327) 26.9 (73) <0.0001 
Hypertension Men 41.0 (786) 55.7 (1000) 59.2 (1151) 58.1 (615) 55.0 (116) <0.0001 
 Women 54.2 (220) 70.4 (425) 71.0 (743) 69.0 (691) 65.7 (178) <0.0001 
Hyperlipidaemia Men 53.2 (1018) 50.9 (913) 48.3 (940) 34.2 (362) 21.3 (45) <0.0001 
 Women 48.5 (197) 55.3 (334) 52.7 (551) 43.1 (432) 23.6 (64) <0.0001 
Family history of CAD Men 33.0 (631) 25.4 (456) 18.4 (357) 12.4 (131) 5.2 (11) <0.0001 
 Women 38.1 (155) 27.8 (168) 21.5 (225) 13.6 (136) 8.5 (23) <0.0001 
Ever smoker Men 83.8 (1605) 73.3 (1315) 69.2 (1347) 68.0 (719) 57.8 (122) <0.0001 
 Women 63.3 (257) 45.4 (274) 32.6 (341) 28.2 (283) 24.4 (66) <0.0001 
Current smoker Men 62.1 (1189) 40.4 (724) 23.7 (461) 13.9 (147) 6.6 (14) <0.0001 
 Women 47.0 (191) 26.2 (158) 13.2 (138) 6.2 (62) 3.3 (9) <0.0001 
Prior AMI Men 22.6 (433) 31.6 (567) 34.8 (678) 40.2 (425) 40.3 (85) <0.0001 
 Women 19.2 (78) 22.5 (136) 29.1 (304) 30.9 (310) 32.5 (88) <0.0001 
Chronic angina Men 20.5 (392) 28.3 (507) 32.5 (632) 36.5 (386) 33.2 (70) <0.0001 
 Women 28.1 (114) 32.6 (197) 36.6 (383) 33.9 (340) 34.3 (93) 0.018 
Prior revascularization Men 15.1 (289) 21.4 (383) 21.3 (415) 19.8 (209) 4.7 (10) 0.01 
 Women 14.5 (59) 13.9 (84) 15.4 (161) 10.1 (101) 4.1 (11) <0.0001 
Prior CVL/TIA Men 1.9 (36) 6.2 (111) 9.3 (181) 12.0 (127) 12.8 (27) <0.0001 
 Women 2.2 (9) 6.6 (40) 7.7 (81) 12.5 (125) 10.7 (29) <0.0001 
Prior heart failure Men 3.8 (73) 7.4 (133) 11.7 (228) 18.5 (196) 29.4 (62) <0.0001 
 Women 5.2 (21) 8.3 (50) 12.3 (129) 19.8 (198) 26.2 (71) <0.0001 
ASA prior to admission Men 30.4 (583) 41.0 (735) 45.9 (894) 52.2 (552) 51.7 (109) <0.0001 
 Women 35.0 (142) 39.4 (238) 42.0 (439) 47.5 (476) 48.0 (130) <0.0001 
Beta-blocker prior to admission Men 26.4 (506) 34.9 (626) 34.3 (668) 37.7 (399) 28.9 (61) <0.0001 
 Women 29.8 (121) 34.8 (210) 35.0 (366) 33.8 (339) 31.4 (85) 0.63 
Statin prior to admission Men 18.2 (348) 24.0 (430) 23.2 (451) 17.7 (187) 7.1 (15) 0.35 
 Women 21.2 (86) 20.7 (125) 23.1 (242) 17.8 (178) 6.6 (18) <0.0001 
Diuretic prior to admission Men 4.8 (91) 9.0 (161) 16.8 (326) 26.8 (284) 36.0 (76) <0.0001 
 Women 10.8 (44) 12.1 (73) 22.1 (231) 31.0 (311) 48.3 (131) <0.0001 
Age group  <55 55–64 65–74 75–84 85+ P for trend 
Men  1915 1794 1946 1058 211  
Women   406  604 1046 1002 271  
% Women  17.5 (406) 25.2 (604) 35.0 (1046) 48.6 (1002) 56.2 (271) <0.0001 
Obese (>30 kg m−2)a Men 23.4 (410) 21.9 (358) 17.7 (303) 12.8 (111) 6.4 (9) <0.0001 
 Women 27.1 (100) 33.6 (181) 28.1 (251) 21.8 (171) 12.2 (21) <0.0001 
Diabetes mellitus Men 13.5 (259) 23.9 (429) 25.2 (491) 22.9 (242) 24.2 (51) <0.0001 
 Women 20.4 (83) 27.3 (165) 30.5 (319) 32.6 (327) 26.9 (73) <0.0001 
Hypertension Men 41.0 (786) 55.7 (1000) 59.2 (1151) 58.1 (615) 55.0 (116) <0.0001 
 Women 54.2 (220) 70.4 (425) 71.0 (743) 69.0 (691) 65.7 (178) <0.0001 
Hyperlipidaemia Men 53.2 (1018) 50.9 (913) 48.3 (940) 34.2 (362) 21.3 (45) <0.0001 
 Women 48.5 (197) 55.3 (334) 52.7 (551) 43.1 (432) 23.6 (64) <0.0001 
Family history of CAD Men 33.0 (631) 25.4 (456) 18.4 (357) 12.4 (131) 5.2 (11) <0.0001 
 Women 38.1 (155) 27.8 (168) 21.5 (225) 13.6 (136) 8.5 (23) <0.0001 
Ever smoker Men 83.8 (1605) 73.3 (1315) 69.2 (1347) 68.0 (719) 57.8 (122) <0.0001 
 Women 63.3 (257) 45.4 (274) 32.6 (341) 28.2 (283) 24.4 (66) <0.0001 
Current smoker Men 62.1 (1189) 40.4 (724) 23.7 (461) 13.9 (147) 6.6 (14) <0.0001 
 Women 47.0 (191) 26.2 (158) 13.2 (138) 6.2 (62) 3.3 (9) <0.0001 
Prior AMI Men 22.6 (433) 31.6 (567) 34.8 (678) 40.2 (425) 40.3 (85) <0.0001 
 Women 19.2 (78) 22.5 (136) 29.1 (304) 30.9 (310) 32.5 (88) <0.0001 
Chronic angina Men 20.5 (392) 28.3 (507) 32.5 (632) 36.5 (386) 33.2 (70) <0.0001 
 Women 28.1 (114) 32.6 (197) 36.6 (383) 33.9 (340) 34.3 (93) 0.018 
Prior revascularization Men 15.1 (289) 21.4 (383) 21.3 (415) 19.8 (209) 4.7 (10) 0.01 
 Women 14.5 (59) 13.9 (84) 15.4 (161) 10.1 (101) 4.1 (11) <0.0001 
Prior CVL/TIA Men 1.9 (36) 6.2 (111) 9.3 (181) 12.0 (127) 12.8 (27) <0.0001 
 Women 2.2 (9) 6.6 (40) 7.7 (81) 12.5 (125) 10.7 (29) <0.0001 
Prior heart failure Men 3.8 (73) 7.4 (133) 11.7 (228) 18.5 (196) 29.4 (62) <0.0001 
 Women 5.2 (21) 8.3 (50) 12.3 (129) 19.8 (198) 26.2 (71) <0.0001 
ASA prior to admission Men 30.4 (583) 41.0 (735) 45.9 (894) 52.2 (552) 51.7 (109) <0.0001 
 Women 35.0 (142) 39.4 (238) 42.0 (439) 47.5 (476) 48.0 (130) <0.0001 
Beta-blocker prior to admission Men 26.4 (506) 34.9 (626) 34.3 (668) 37.7 (399) 28.9 (61) <0.0001 
 Women 29.8 (121) 34.8 (210) 35.0 (366) 33.8 (339) 31.4 (85) 0.63 
Statin prior to admission Men 18.2 (348) 24.0 (430) 23.2 (451) 17.7 (187) 7.1 (15) 0.35 
 Women 21.2 (86) 20.7 (125) 23.1 (242) 17.8 (178) 6.6 (18) <0.0001 
Diuretic prior to admission Men 4.8 (91) 9.0 (161) 16.8 (326) 26.8 (284) 36.0 (76) <0.0001 
 Women 10.8 (44) 12.1 (73) 22.1 (231) 31.0 (311) 48.3 (131) <0.0001 

CAD, coronary artery disease; CVL, cerebrovascular lesion; TIA, transient ischaemic attack.

aMissing in 1398 subjects.

View Large
Table 2

Clinical presentation and initial and discharge diagnoses by age in the Euroheart ACS survey

Age group  <55 55–64 65–74 75–84 ≥85 P for trend 
Men  1915 1794 1946 1058 211  
Women   406  604 1046 1002 271  
Symptoms        
 Typical angina Men 90.9 (1740) 89.5 (1606) 85.9 (1672) 83.7 (886) 79.6 (168) <0.0001 
 Women 88.2 (358) 86.3 (521) 86.3 (903) 83.4 (836) 74.9 (203) <0.0001 
 Atypical chest pain Men 4.9 (93) 3.5 (63) 5.3 (104) 4.3 (45) 2.8 (6) 0.52 
 Women 5.4 (22) 7.8 (47) 4.7 (49) 4.9 (49) 6.6 (18) 0.61 
 Killip class 3–4 on arrival Men 2.6 (50) 3.4 (60) 4.8 (93) 7.5 (79) 13.7 (29) <0.0001 
 Women 2.3 (9) 4.5 (27) 5.4 (56) 8.7 (87) 17.0 (46) <0.0001 
Initial diagnosis, % (n)        
 ACS with ST-elevation Men 55.6 (1064) 45.9 (823) 39.6 (771) 36.3 (384) 37.9 (80) <0.0001 
 Women 43.8 (178) 35.6 (215) 36.7 (384) 35.6 (357) 38.8 (105) 0.06 
 ACS, no ST-elevation Men 45.7 (818) 49.5 (888) 52.5 (1022) 51.2 (542) 46.0 (97) <0.0001 
 Women 53.9 (219) 59.6 (360) 56.8 (594) 55.3 (554) 49.5 (134) 0.19 
 Undetermined Men 1.7 (33) 4.6 (83) 7.9 (153) 12.5 (132) 16.1 (34) <0.0001 
 Women 2.2 (9) 4.8 (29) 6.5 (68) 9.1 (91) 11.8 (32) <0.0001 
Discharge diagnosis, % (n)        
 Q-wave MI Men 44.0 (843) 35.6 (639) 30.8 (600) 27.0 (286) 32.7 (69) <0.0001 
 Women 28.8 (117) 27.0 (163) 27.3 (285) 27.4 (274) 32.1 (87) 0.66 
 Non-Q-wave MI Men 23.0 (441) 23.7 (425) 23.2 (452) 30.1 (318) 32.7 (69) 0.0002 
 Women 26.1 (106) 24.0 (145) 22.8 (238) 27.2 (272) 37.6 (102) 0.004 
 Unstable angina Men 33.0 (631) 40.7 (730) 45.9 (894) 42.9 (454) 34.6 (73) <0.0001 
 Women 45.1 (183) 49.0 (296) 50.0 (523) 45.5 (456) 30.3 (82) 0.003 
Age group  <55 55–64 65–74 75–84 ≥85 P for trend 
Men  1915 1794 1946 1058 211  
Women   406  604 1046 1002 271  
Symptoms        
 Typical angina Men 90.9 (1740) 89.5 (1606) 85.9 (1672) 83.7 (886) 79.6 (168) <0.0001 
 Women 88.2 (358) 86.3 (521) 86.3 (903) 83.4 (836) 74.9 (203) <0.0001 
 Atypical chest pain Men 4.9 (93) 3.5 (63) 5.3 (104) 4.3 (45) 2.8 (6) 0.52 
 Women 5.4 (22) 7.8 (47) 4.7 (49) 4.9 (49) 6.6 (18) 0.61 
 Killip class 3–4 on arrival Men 2.6 (50) 3.4 (60) 4.8 (93) 7.5 (79) 13.7 (29) <0.0001 
 Women 2.3 (9) 4.5 (27) 5.4 (56) 8.7 (87) 17.0 (46) <0.0001 
Initial diagnosis, % (n)        
 ACS with ST-elevation Men 55.6 (1064) 45.9 (823) 39.6 (771) 36.3 (384) 37.9 (80) <0.0001 
 Women 43.8 (178) 35.6 (215) 36.7 (384) 35.6 (357) 38.8 (105) 0.06 
 ACS, no ST-elevation Men 45.7 (818) 49.5 (888) 52.5 (1022) 51.2 (542) 46.0 (97) <0.0001 
 Women 53.9 (219) 59.6 (360) 56.8 (594) 55.3 (554) 49.5 (134) 0.19 
 Undetermined Men 1.7 (33) 4.6 (83) 7.9 (153) 12.5 (132) 16.1 (34) <0.0001 
 Women 2.2 (9) 4.8 (29) 6.5 (68) 9.1 (91) 11.8 (32) <0.0001 
Discharge diagnosis, % (n)        
 Q-wave MI Men 44.0 (843) 35.6 (639) 30.8 (600) 27.0 (286) 32.7 (69) <0.0001 
 Women 28.8 (117) 27.0 (163) 27.3 (285) 27.4 (274) 32.1 (87) 0.66 
 Non-Q-wave MI Men 23.0 (441) 23.7 (425) 23.2 (452) 30.1 (318) 32.7 (69) 0.0002 
 Women 26.1 (106) 24.0 (145) 22.8 (238) 27.2 (272) 37.6 (102) 0.004 
 Unstable angina Men 33.0 (631) 40.7 (730) 45.9 (894) 42.9 (454) 34.6 (73) <0.0001 
 Women 45.1 (183) 49.0 (296) 50.0 (523) 45.5 (456) 30.3 (82) 0.003 
View Large
Table 3

Angiographic findings by age in the Euroheart ACS survey among 5374 patients <85 years

Age group  <55 55–64 65–74 75–84 P for trend 
Men with angiography (% with angiography)  1272 (66) 1131 (63) 1107 (57) 444 (42)  
Women with angiography (% with angiography)   240 (59)  332 (55)  499 (48) 349 (35)  
Normal angiogram (%) Men 5.6 (71) 3.8 (43) 2.7 (30) 2.3 (10) <0.0001 
 Women 13.3 (32) 10.8 (36) 7.2 (36) 5.7 (20) <0.0001 
Number of diseased vessels (≥50% stenosis) (%)       
 0 Men 6.5 (83) 4.9 (55) 4.4 (49) 3.8 (17)  
 Women 15.0 (36) 12.1 (40) 8.2 (41) 6.9 (24)  
 1 Men 40.3 (513) 31.0 (351) 24.2 (268) 19.6 (87)  
 Women 43.3 (104) 33.7 (112) 27.9 (139) 23.2 (81)  
 2 Men 29.1 (370) 28.9 (327) 32.5 (360) 30.0 (133)  
 Women 25.0 (60) 24.4 (81) 29.9 (149) 29.8 (104)  
 3 Men 24.1 (306) 35.2 (398) 38.8 (430) 46.6 (207) <0.0001 
 Women 16.7 (40) 29.8 (99) 34.1 (170) 40.1 (140) <0.0001 
Left main stem ≥50% stenosis (%) Men 6.1 (78) 10.6 (120) 17.3 (192) 18.2 (81) <0.0001 
 Women 5.0 (12) 6.9 (23) 10.6 (53) 17.2 (60) <0.0001 
Three-vessel disease or main stem (%) Men 27.1 (345) 39.6 (448) 46.0 (509) 54.1 (240) <0.0001 
 Women 18.3 (44) 32.5 (108) 37.9 (189) 47.6 (166) <0.0001 
PCI or CABG while in hospital Men 71.6 (911) 70.0 (792) 63.7 (705) 61.0 (271) <0.0001 
 Women 62.5 (150) 62.1 (206) 59.9 (299) 63.3 (221) <0.0001 
Age group  <55 55–64 65–74 75–84 P for trend 
Men with angiography (% with angiography)  1272 (66) 1131 (63) 1107 (57) 444 (42)  
Women with angiography (% with angiography)   240 (59)  332 (55)  499 (48) 349 (35)  
Normal angiogram (%) Men 5.6 (71) 3.8 (43) 2.7 (30) 2.3 (10) <0.0001 
 Women 13.3 (32) 10.8 (36) 7.2 (36) 5.7 (20) <0.0001 
Number of diseased vessels (≥50% stenosis) (%)       
 0 Men 6.5 (83) 4.9 (55) 4.4 (49) 3.8 (17)  
 Women 15.0 (36) 12.1 (40) 8.2 (41) 6.9 (24)  
 1 Men 40.3 (513) 31.0 (351) 24.2 (268) 19.6 (87)  
 Women 43.3 (104) 33.7 (112) 27.9 (139) 23.2 (81)  
 2 Men 29.1 (370) 28.9 (327) 32.5 (360) 30.0 (133)  
 Women 25.0 (60) 24.4 (81) 29.9 (149) 29.8 (104)  
 3 Men 24.1 (306) 35.2 (398) 38.8 (430) 46.6 (207) <0.0001 
 Women 16.7 (40) 29.8 (99) 34.1 (170) 40.1 (140) <0.0001 
Left main stem ≥50% stenosis (%) Men 6.1 (78) 10.6 (120) 17.3 (192) 18.2 (81) <0.0001 
 Women 5.0 (12) 6.9 (23) 10.6 (53) 17.2 (60) <0.0001 
Three-vessel disease or main stem (%) Men 27.1 (345) 39.6 (448) 46.0 (509) 54.1 (240) <0.0001 
 Women 18.3 (44) 32.5 (108) 37.9 (189) 47.6 (166) <0.0001 
PCI or CABG while in hospital Men 71.6 (911) 70.0 (792) 63.7 (705) 61.0 (271) <0.0001 
 Women 62.5 (150) 62.1 (206) 59.9 (299) 63.3 (221) <0.0001 
View Large
Table 4

Hospital complications by age in the Euroheart ACS survey

Age group  <55 55–64 65–74 75–84 ≥85 P for trend 
Men  1915 1794 1946 1058 211  
Women   406  604 1046 1002 271  
Mild to moderate heart failure (%) Men 10.2 (196) 14.6 (261) 18.1 (352) 21.0 (222) 31.8 (67) <0.0001 
 Women 11.3 (46) 14.9 (90) 17.4 (182) 23.5 (235) 29.5 (80) <0.0001 
Pulmonary oedema (%) Men 2.3 (44) 3.8 (68) 5.6 (109) 10.2 (108) 17.5 (37) <0.0001 
 Women 4.2 (17) 5.1 (31) 7.0 (73) 12.0 (120) 15.5 (42) <0.0001 
Shock (%) Men 3.0 (57) 3.3 (59) 4.9 (95) 5.8 (61) 8.5 (18) <0.0001 
 Women 4.7 (19) 5.3 (32) 5.0 (52) 6.4 (64) 6.6 (18) 0.11 
Any heart failure, including shock (%) Men 12.8 (245) 17.6 (316) 22.2 (431) 28.1 (297) 43.1 (91) <0.0001 
 Women 14.5 (59) 20.2 (122) 22.8 (238) 30.6 (307) 40.6 (110) <0.0001 
Asystole (%) Men 1.3 (25) 1.5 (27) 3.6 (69) 4.5 (48) 9.0 (19) <0.0001 
 Women 1.7 (7) 2.7 (16) 3.8 (40) 5.5 (55) 10.0 (27) <0.0001 
Atrial fibrillation (%) Men 2.7 (51) 5.4 (97) 8.4 (163) 11.6 (123) 15.6 (33) <0.0001 
 Women 2.7 (11) 4.3 (26) 7.0 (73) 11.6 (116) 9.2 (25) <0.0001 
Recurrent ischaemia (%) Men 10.6 (202) 10.6 (190) 12.4 (242) 12.6 (133) 13.3 (28) 0.01 
 Women 13.6 (55) 13.1 (79) 11.9 (124) 14.7 (147) 11.4 (31) 0.75 
Re-infarction (%) Men 1.3 (24) 1.6 (29) 2.4 (47) 2.6 (27) 2.4 (5) 0.006 
 Women 2.5 (10) 2.0 (12) 1.9 (20) 2.4 (24) 0.7 (2) 0.46 
Age group  <55 55–64 65–74 75–84 ≥85 P for trend 
Men  1915 1794 1946 1058 211  
Women   406  604 1046 1002 271  
Mild to moderate heart failure (%) Men 10.2 (196) 14.6 (261) 18.1 (352) 21.0 (222) 31.8 (67) <0.0001 
 Women 11.3 (46) 14.9 (90) 17.4 (182) 23.5 (235) 29.5 (80) <0.0001 
Pulmonary oedema (%) Men 2.3 (44) 3.8 (68) 5.6 (109) 10.2 (108) 17.5 (37) <0.0001 
 Women 4.2 (17) 5.1 (31) 7.0 (73) 12.0 (120) 15.5 (42) <0.0001 
Shock (%) Men 3.0 (57) 3.3 (59) 4.9 (95) 5.8 (61) 8.5 (18) <0.0001 
 Women 4.7 (19) 5.3 (32) 5.0 (52) 6.4 (64) 6.6 (18) 0.11 
Any heart failure, including shock (%) Men 12.8 (245) 17.6 (316) 22.2 (431) 28.1 (297) 43.1 (91) <0.0001 
 Women 14.5 (59) 20.2 (122) 22.8 (238) 30.6 (307) 40.6 (110) <0.0001 
Asystole (%) Men 1.3 (25) 1.5 (27) 3.6 (69) 4.5 (48) 9.0 (19) <0.0001 
 Women 1.7 (7) 2.7 (16) 3.8 (40) 5.5 (55) 10.0 (27) <0.0001 
Atrial fibrillation (%) Men 2.7 (51) 5.4 (97) 8.4 (163) 11.6 (123) 15.6 (33) <0.0001 
 Women 2.7 (11) 4.3 (26) 7.0 (73) 11.6 (116) 9.2 (25) <0.0001 
Recurrent ischaemia (%) Men 10.6 (202) 10.6 (190) 12.4 (242) 12.6 (133) 13.3 (28) 0.01 
 Women 13.6 (55) 13.1 (79) 11.9 (124) 14.7 (147) 11.4 (31) 0.75 
Re-infarction (%) Men 1.3 (24) 1.6 (29) 2.4 (47) 2.6 (27) 2.4 (5) 0.006 
 Women 2.5 (10) 2.0 (12) 1.9 (20) 2.4 (24) 0.7 (2) 0.46 
View Large
Table 5

Selected treatments and investigations by age in the Euroheart ACS survey

Age group  <55 55–64 65–74 75–84 ≥85 P for trend 
Men  1915 1794 1946 1058 211  
Women   406  604 1046 1002 271  
First ward coronary care unit (%) Men 72.8 (1394) 64.2 (1151) 61.9 (1205) 58.1 (615) 49.8 (105) <0.0001 
 Women 62.1 (252) 60.8 (367) 58.3 (610) 56.1 (562) 47.2 (128) <0.0001 
First ward any cardiology unit (%) Men 90.8 (1738) 86.4 (1550) 83.5 (1625) 82.3 (871) 74.4 (157) <0.0001 
 Women 84.7 (344) 86.6 (523) 82.5 (863) 77.6 (778) 72.0 (195) <0.0001 
ASA or any other anti-trombotic treatment on discharge, % (n) Men 94.1 (1802) 92.9 (1667) 89.7 (1746) 87.2 (922) 82.5 (174) <0.0001 
 Women 94.3 (383) 90.6 (547) 88.4 (925) 87.4 (876) 80.8 (219) <0.0001 
ACE inhibitors on discharge (%) Men 50.4 (966) 55.4 (994) 59.3 (1153) 55.9 (591) 46.5 (98) 0.002 
 Women 46.3 (188) 58.1 (351) 58.9 (616) 56.7 (568) 52.8 (143) 0.06 
Beta-blockers on discharge (%) Men 81.6 (1562) 77.8 (1395) 68.6 (1334) 65.2 (690) 48.8 (103) <0.0001 
 Women 76.1 (309) 76.0 (459) 70.9 (742) 62.7 (628) 53.5 (145) <0.0001 
Statins on discharge (%) Men 61.5 (1177) 59.9 (1075) 52.8 (1028) 38.2 (404) 15.6 (33) <0.0001 
 Women 57.1 (232) 56.3 (340) 53.4 (558) 42.3 (424) 17.7 (48) <0.0001 
Angiography while in hospital (%) Men 66.4 (1272) 63.0 (1131) 56.9 (1107) 42.0 (444) 18.0 (38) <0.0001 
 Women 59.1 (240) 55.0 (332) 47.7 (499) 34.8 (349) 9.2 (25) <0.0001 
Evaluation of left ventricular function in hospital (%) Men 81.9 (1569) 80.9 (1452) 75.4 (1467) 70.4 (745) 55.9 (118) <0.0001 
 Women 81.8 (332) 79.8 (482) 76.2 (797) 68.7 (688) 52.0 (141) <0.0001 
PCI while in hospital, % (n) Men 44.5 (852) 39.7 (712) 30.5 (593) 22.5 (238) 10.9 (23) <0.0001 
 Women 35.2 (143) 30.8 (186) 24.7 (258) 19.7 (197) 7.0 (19) <0.0001 
In patients with ACS with ST-elevation (n) and presenting within 12 h Men 769 586 524 263 64  
 Women 123 158 263 235 58  
Thrombolytic therapy, % (n) Men 43.2 (332) 44.2 (259) 44.9 (235) 35.0 (92) 17.2 (11) 0.02 
 Women 47.2 (58) 44.9 (71) 43.4 (114) 31.1 (73) 13.8 (8) <0.0001 
Primary PCI, % (n) Men 26.5 (204) 27.1 (159) 21.0 (110) 20.9 (55) 14.1 (9) 0.002 
 Women 29.3 (36) 21.5 (34) 17.9 (47) 16.6 (39) 6.9 (4) <0.0001 
Thrombolytic or primary PCI, % (n) Men 69.7 (536) 71.3 (418) 65.8 (345) 55.6 (147) 31.3 (20) <0.0001 
 Women 76.4 (94) 66.5 (105) 61.2 (161) 47.7 (112) 20.7 (12) <0.0001 
Age group  <55 55–64 65–74 75–84 ≥85 P for trend 
Men  1915 1794 1946 1058 211  
Women   406  604 1046 1002 271  
First ward coronary care unit (%) Men 72.8 (1394) 64.2 (1151) 61.9 (1205) 58.1 (615) 49.8 (105) <0.0001 
 Women 62.1 (252) 60.8 (367) 58.3 (610) 56.1 (562) 47.2 (128) <0.0001 
First ward any cardiology unit (%) Men 90.8 (1738) 86.4 (1550) 83.5 (1625) 82.3 (871) 74.4 (157) <0.0001 
 Women 84.7 (344) 86.6 (523) 82.5 (863) 77.6 (778) 72.0 (195) <0.0001 
ASA or any other anti-trombotic treatment on discharge, % (n) Men 94.1 (1802) 92.9 (1667) 89.7 (1746) 87.2 (922) 82.5 (174) <0.0001 
 Women 94.3 (383) 90.6 (547) 88.4 (925) 87.4 (876) 80.8 (219) <0.0001 
ACE inhibitors on discharge (%) Men 50.4 (966) 55.4 (994) 59.3 (1153) 55.9 (591) 46.5 (98) 0.002 
 Women 46.3 (188) 58.1 (351) 58.9 (616) 56.7 (568) 52.8 (143) 0.06 
Beta-blockers on discharge (%) Men 81.6 (1562) 77.8 (1395) 68.6 (1334) 65.2 (690) 48.8 (103) <0.0001 
 Women 76.1 (309) 76.0 (459) 70.9 (742) 62.7 (628) 53.5 (145) <0.0001 
Statins on discharge (%) Men 61.5 (1177) 59.9 (1075) 52.8 (1028) 38.2 (404) 15.6 (33) <0.0001 
 Women 57.1 (232) 56.3 (340) 53.4 (558) 42.3 (424) 17.7 (48) <0.0001 
Angiography while in hospital (%) Men 66.4 (1272) 63.0 (1131) 56.9 (1107) 42.0 (444) 18.0 (38) <0.0001 
 Women 59.1 (240) 55.0 (332) 47.7 (499) 34.8 (349) 9.2 (25) <0.0001 
Evaluation of left ventricular function in hospital (%) Men 81.9 (1569) 80.9 (1452) 75.4 (1467) 70.4 (745) 55.9 (118) <0.0001 
 Women 81.8 (332) 79.8 (482) 76.2 (797) 68.7 (688) 52.0 (141) <0.0001 
PCI while in hospital, % (n) Men 44.5 (852) 39.7 (712) 30.5 (593) 22.5 (238) 10.9 (23) <0.0001 
 Women 35.2 (143) 30.8 (186) 24.7 (258) 19.7 (197) 7.0 (19) <0.0001 
In patients with ACS with ST-elevation (n) and presenting within 12 h Men 769 586 524 263 64  
 Women 123 158 263 235 58  
Thrombolytic therapy, % (n) Men 43.2 (332) 44.2 (259) 44.9 (235) 35.0 (92) 17.2 (11) 0.02 
 Women 47.2 (58) 44.9 (71) 43.4 (114) 31.1 (73) 13.8 (8) <0.0001 
Primary PCI, % (n) Men 26.5 (204) 27.1 (159) 21.0 (110) 20.9 (55) 14.1 (9) 0.002 
 Women 29.3 (36) 21.5 (34) 17.9 (47) 16.6 (39) 6.9 (4) <0.0001 
Thrombolytic or primary PCI, % (n) Men 69.7 (536) 71.3 (418) 65.8 (345) 55.6 (147) 31.3 (20) <0.0001 
 Women 76.4 (94) 66.5 (105) 61.2 (161) 47.7 (112) 20.7 (12) <0.0001 
View Large
Table 6

Impact of age on risk of ST-elevation ACS and on-hospital mortality by diagnosis

 n % Odds ratio (95% CI) Odds ratioa (95% CI) 
ST elevation ACS     
<55 2321 53.5 (1242)  1.00  1.00 
55–64 2398 43.3 (1038) 0.66 (0.59–0.74) 0.67 (0.61–0.75) 
65–74 2992 38.6 (1155) 0.55 (0.49–0.61) 0.55 (0.49–0.63) 
75–84 2060 36.0 (741) 0.49 (0.43–0.55) 0.50 (0.42–0.61) 
≥85 482 38.4 (185) 0.54 (0.44–0.66) 0.57 (0.44–0.74) 
Total 10 253 42.5 (486)   
Hospital mortality     
ACS with ST elevation     
<55 1242 1.8 (22)  1.00  1.00 
55–64 1038 4.0 (41) 2.28 (1.35–3.85) 2.29 (1.37–3.82) 
65–74 1155 8.4 (97) 5.08 (3.18–8.14) 5.07 (2.88–8.92) 
75–84 741 12.2 (90) 7.67 (4.76–12.34) 7.78 (4.65–12.99) 
≥85 185 23.2 (43) 16.79 (9.76–28.88) 16.91 (9.28–30.79) 
Total 4361 6.7 (293)   
ACS without ST elevation     
<55 1037 0.9 (9)  1.00  1.00 
55–64 1248 1.0 (13) 1.20 (0.51–2.82) 1.21 (0.61–2.38) 
65–74 1616 2.0 (32) 2.31 (1.10–4.85) 2.20 (1.08–4.47) 
75–84 1096 4.1 (45) 4.89 (2.38–10.06) 4.50 (2.34–8.65) 
≥85 231 8.7 (20) 10.83 (4.86–24.11) 9.74 (4.51–21.06) 
Total 5228 2.3 (119)   
ACS with undetermined ECG     
<55 42 2.4 (1)  1.00  1.00 
55–64 112 6.3 (7) 2.73 (0.33–22.91) 2.82 (0.49–16.35) 
65–74 221 8.1 (18) 3.64 (0.47–27.99) 3.82 (0.60–24.44) 
75–84 223 13.5 (30) 6.37 (0.85–48.06) 6.71 (1.01–44.40) 
≥85 66 27.3 (18) 15.37 (1.97–120.15) 15.68 (2.25–109.42) 
Total 664 11.1 (74)   
All     
<55 2321 1.4 (32)  1.00  1.00 
55–64 2398 2.5 (61) 1.87 (1.21–2.88) 1.83 (1.25–2.67) 
65–74 2992 4.9 (147) 3.70 (2.51–5.44) 3.54 (2.36–5.30) 
75–84 2060 8.0 (165) 6.23 (4.25–9.14) 5.97 (4.13–8.63) 
≥85 482 16.8 (81) 14.45 (9.47–22.1) 13.47 (8.63–21.03) 
Total 10 253 4.7 (486)   
 n % Odds ratio (95% CI) Odds ratioa (95% CI) 
ST elevation ACS     
<55 2321 53.5 (1242)  1.00  1.00 
55–64 2398 43.3 (1038) 0.66 (0.59–0.74) 0.67 (0.61–0.75) 
65–74 2992 38.6 (1155) 0.55 (0.49–0.61) 0.55 (0.49–0.63) 
75–84 2060 36.0 (741) 0.49 (0.43–0.55) 0.50 (0.42–0.61) 
≥85 482 38.4 (185) 0.54 (0.44–0.66) 0.57 (0.44–0.74) 
Total 10 253 42.5 (486)   
Hospital mortality     
ACS with ST elevation     
<55 1242 1.8 (22)  1.00  1.00 
55–64 1038 4.0 (41) 2.28 (1.35–3.85) 2.29 (1.37–3.82) 
65–74 1155 8.4 (97) 5.08 (3.18–8.14) 5.07 (2.88–8.92) 
75–84 741 12.2 (90) 7.67 (4.76–12.34) 7.78 (4.65–12.99) 
≥85 185 23.2 (43) 16.79 (9.76–28.88) 16.91 (9.28–30.79) 
Total 4361 6.7 (293)   
ACS without ST elevation     
<55 1037 0.9 (9)  1.00  1.00 
55–64 1248 1.0 (13) 1.20 (0.51–2.82) 1.21 (0.61–2.38) 
65–74 1616 2.0 (32) 2.31 (1.10–4.85) 2.20 (1.08–4.47) 
75–84 1096 4.1 (45) 4.89 (2.38–10.06) 4.50 (2.34–8.65) 
≥85 231 8.7 (20) 10.83 (4.86–24.11) 9.74 (4.51–21.06) 
Total 5228 2.3 (119)   
ACS with undetermined ECG     
<55 42 2.4 (1)  1.00  1.00 
55–64 112 6.3 (7) 2.73 (0.33–22.91) 2.82 (0.49–16.35) 
65–74 221 8.1 (18) 3.64 (0.47–27.99) 3.82 (0.60–24.44) 
75–84 223 13.5 (30) 6.37 (0.85–48.06) 6.71 (1.01–44.40) 
≥85 66 27.3 (18) 15.37 (1.97–120.15) 15.68 (2.25–109.42) 
Total 664 11.1 (74)   
All     
<55 2321 1.4 (32)  1.00  1.00 
55–64 2398 2.5 (61) 1.87 (1.21–2.88) 1.83 (1.25–2.67) 
65–74 2992 4.9 (147) 3.70 (2.51–5.44) 3.54 (2.36–5.30) 
75–84 2060 8.0 (165) 6.23 (4.25–9.14) 5.97 (4.13–8.63) 
≥85 482 16.8 (81) 14.45 (9.47–22.1) 13.47 (8.63–21.03) 
Total 10 253 4.7 (486)   

aAdjusted for sex, prior MI, hypertension, diabetes, chronic angina, prior revascularization, and known prior heart failure.

View Large

References

1
Dauerman HL, Lessard D, Yarzebski J, Furman MI, Gore JM, Goldberg RJ. Ten-year trends in the incidence, treatment, and outcome of Q-wave myocardial infarction.
Am J Cardiol
 
2000
;
86
:
730
–735.
Google Scholar
2
Goff DC Jr, Howard G, Wang CH, Folsom AR, Rosamond WD, Cooper LS, Chambless LE. Trends in severity of hospitalized myocardial infarction: the atherosclerosis risk in communities (ARIC) study, 1987–1994.
Am Heart J
 
2000
;
139
:
874
–880.
Google Scholar
3
Hellermann JP, Reeder GS, Jacobsen SJ, Weston SA, Killian JM, Roger VL. Longitudinal trends in the severity of acute myocardial infarction: a population study in Olmsted County, Minnesota.
Am J Epidemiol
 
2002
;
156
:
246
–253.
Google Scholar
4
Salomaa V, Miettinen H, Palomaki P, Arstila M, Mustaniemi H, Kuulasmaa K, Tuomilehto J. Diagnostic features of acute myocardial infarction—changes over time from 1983 to 1990: results from the FINMONICA AMI Register Study.
J Intern Med
 
1995
;
237
:
151
–159.
Google Scholar
5
Abildstrom SZ, Rasmussen S, Rosen M, Madsen M. Trends in incidence and case fatality rates of acute myocardial infarction in Denmark and Sweden.
Heart
 
2003
;
89
:
507
–511.
Google Scholar
6
McGovern PG, Jacobs DR Jr, Shahar E, Arnett DK, Folsom AR, Blackburn H, Luepker RV. Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey.
Circulation
 
2001
;
104
:
19
–24.
Google Scholar
7
Goldberg RJ, Gore JM, Gurwitz JH, Alpert JS, Brady P, Strohsnitter W, Chen ZY, Dalen JE. The impact of age on the incidence and prognosis of initial acute myocardial infarction: the Worcester Heart Attack Study.
Am Heart J
 
1989
;
117
:
543
–549.
Google Scholar
8
Goldberg RJ, McCormick D, Gurwitz JH, Yarzebski J, Lessard D, Gore JM. Age-related trends in short- and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975–1995).
Am J Cardiol
 
1998
;
82
:
1311
–1317.
Google Scholar
9
Lee KL, Woodlief LH, Topol EJ, Weaver WD, Betriu A, Col J, Simoons M, Aylward P, Van de Werf F, Califf RM. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators.
Circulation
 
1995
;
91
:
1659
–1668.
Google Scholar
10
Newby LK, Bhapkar MV, White HD, Topol EJ, Dougherty FC, Harrington RA, Smith MC, Asarch LF, Califf RM. Predictors of 90-day outcome in patients stabilized after acute coronary syndromes.
Eur Heart J
 
2003
;
24
:
172
–181.
Google Scholar
11
Rosengren A, Spetz CL, Koster M, Hammar N, Alfredsson L, Rosen M. Sex differences in survival after myocardial infarction in Sweden; data from the Swedish National Acute Myocardial Infarction Register.
Eur Heart J
 
2001
;
22
:
314
–322.
Google Scholar
12
Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants.
N Engl J Med
 
1999
;
341
:
217
–225.
Google Scholar
13
Avezum A, Makdisse M, Spencer F, Gore JM, Fox KA, Montalescot G, Eagle KA, White K, Mehta RH, Knobel E, Collet JP. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE).
Am Heart J
 
2005
;
149
:
67
–73.
Google Scholar
14
Halon DA, Adawi S, Dobrecky-Mery I, Lewis BS. Importance of increasing age on the presentation and outcome of acute coronary syndromes in elderly patients.
J Am Coll Cardiol
 
2004
;
43
:
346
–352.
Google Scholar
15
Stern S, Behar S, Leor J, Harpaz D, Boyko V, Gottlieb S. Presenting symptoms, admission electrocardiogram, management, and prognosis in acute coronary syndromes: differences by age.
Am J Geriatr Cardiol
 
2004
;
13
:
188
–196.
Google Scholar
16
Hasdai D, Behar S, Wallentin L, Danchin N, Gitt AK, Boersma E, Fioretti PM, Simoons ML, Battler A. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS).
Eur Heart J
 
2002
;
23
:
1190
–1201.
Google Scholar
17
Lev EI, Battler A, Behar S, Porter A, Haim M, Boyko V, Hasdai D. Frequency, characteristics, and outcome of patients hospitalized with acute coronary syndromes with undetermined electrocardiographic patterns.
Am J Cardiol
 
2003
;
91
:
224
–227.
Google Scholar
18
Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, Evans A, Ferrario M, Tuomilehto J. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations.
Lancet
 
2000
;
355
:
675
–687.
Google Scholar
19
Tunstall-Pedoe H, Vanuzzo D, Hobbs M, Mahonen M, Cepaitis Z, Kuulasmaa K, Keil U. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations.
Lancet
 
2000
;
355
:
688
–700.
Google Scholar
20
Sans S, Kesteloot H, Kromhout D. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe.
Eur Heart J
 
1997
;
18
:
1231
–1248.
Google Scholar
21
Capewell S, MacIntyre K, Stewart S, Chalmers JW, Boyd J, Finlayson A, Redpath A, Pell JP, McMurray JJ. Age, sex, and social trends in out-of-hospital cardiac deaths in Scotland 1986-95: a retrospective cohort study.
Lancet
 
2001
;
358
:
1213
–1217.
Google Scholar
22
Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000.
Circulation
 
2004
;
109
:
1101
–1107.
Google Scholar
23
Unal B, Critchley JA, Fidan D, Capewell S. Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981–2000.
Am J Public Health
 
2005
;
95
:
103
–108.
Google Scholar
24
Greenland P, Reicher-Reiss H, Goldbourt U, Behar S. In-hospital and 1-year mortality in 1,524 women after myocardial infarction. Comparison with 4,315 men.
Circulation
 
1991
;
83
:
484
–491.
Google Scholar
25
Hasdai D, Holmes DR Jr, Criger DA, Topol EJ, Califf RM, Harrington RA. Age and outcome after acute coronary syndromes without persistent ST-segment elevation.
Am Heart J
 
2000
;
139
:
858
–866.
Google Scholar
26
Ruiz-Bailen M, Aguayo de Hoyos E, Ramos-Cuadra JA, Diaz-Castellanos MA, Issa-Khozouz Z, Reina-Toral A, Lopez-Martinez A, Calatrava-Lopez J, Laynez-Bretones F, Castillo-Parra JC, De La Torre-Prados MV. Influence of age on clinical course, management and mortality of acute myocardial infarction in the Spanish population.
Int J Cardiol
 
2002
;
85
:
285
–296.
Google Scholar
27
Eagle KA, Goodman SG, Avezum A, Budaj A, Sullivan CM, Lopez-Sendon J. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE).
Lancet
 
2002
;
359
:
373
–377.
Google Scholar
28
Chandra H, Yarzebski J, Goldberg RJ, Savageau J, Singleton C, Gurwitz JH, Gore JM. Age-related trends (1986–1993) in the use of thrombolytic agents in patients with acute myocardial infarction. The Worcester Heart Attack Study.
Arch Intern Med
 
1997
;
157
:
741
–746.
Google Scholar
29
Stenestrand U, Wallentin L. Fibrinolytic therapy in patients 75 years and older with ST-segment-elevation myocardial infarction: one-year follow-up of a large prospective cohort.
Arch Intern Med
 
2003
;
163
:
965
–971.
Google Scholar
30
Tran CT, Laupacis A, Mamdani MM, Tu JV. Effect of age on the use of evidence-based therapies for acute myocardial infarction.
Am Heart J
 
2004
;
148
:
834
–841.
Google Scholar
31
Stone PH, Thompson B, Anderson HV, Kronenberg MW, Gibson RS, Rogers WJ, Diver DJ, Theroux P, Warnica JW, Nasmith JB, Kells C, Kleiman N, McCabe CH, Schactman M, Knatterud GL, Braunwald E. Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry.
JAMA
 
1996
;
275
:
1104
–1112.
Google Scholar
32
Canto JG, Shlipak MG, Rogers WJ, Malmgren JA, Frederick PD, Lambrew CT, Ornato JP, Barron HV, Kiefe CI. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain.
JAMA
 
2000
;
283
:
3223
–3229.
Google Scholar
33
Bach RG, Cannon CP, Weintraub WS, DiBattiste PM, Demopoulos LA, Anderson HV, DeLucca PT, Mahoney EM, Murphy SA, Braunwald E. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes.
Ann Intern Med
 
2004
;
141
:
186
–195.
Google Scholar
34
Hasdai D, Behar S, Boyko V, Danchin N, Bassand JP, Battler A. Cardiac biomarkers and acute coronary syndromes—the Euro Heart Survey of Acute Coronary Syndromes Experience.
Eur Heart J
 
2003
;
24
:
1189
–1194.
Google Scholar
© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Issue Section:
Coronary heart disease
Download All Figures

Comments

0 Comments
Comments (0)